Analysts anticipate Quest Diagnostics to report an earnings per share (EPS) of $2.27.
The announcement from Quest Diagnostics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
During the last quarter, the company reported an EPS beat by $0.01, leading to a 2.09% increase in the share price on the subsequent day.
Here's a look at Quest Diagnostics's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
2.34
1.85
2.11
2.19
EPS Actual
2.35
2.04
2.15
2.22
Price Change %
2.0%
1.0%
-2.0%
2.0%
Performance of Quest Diagnostics Shares
Shares of Quest Diagnostics were trading at $149.65 as of October 18. Over the last 52-week period, shares are up 19.88%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst Views on Quest Diagnostics
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Quest Diagnostics.
The consensus rating for Quest Diagnostics is Neutral, derived from 5 analyst ratings. An average one-year price target of $157.6 ...
